Kite Pharma, Inc. Investing Cash Flow
Kite Pharma, Inc. reported Investing Cash Flow of -$112.94 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2017-02-28
- Kite Pharma, Inc. net cash provided by (used in) investing activities for fiscal 2016 was -$112.94M.
- Kite Pharma, Inc. net cash provided by (used in) investing activities for fiscal 2015 was -$106.54M.
- Kite Pharma, Inc. net cash provided by (used in) investing activities for fiscal 2014 was -$160.14M.
| Period end | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|
| 2016-12-31 | -$112.94M 10-K · filed 2017-02-28 |
| 2015-12-31 | -$106.54M 10-K · filed 2017-02-28 |
| 2014-12-31 | -$160.14M 10-K · filed 2017-02-28 |